Hemifacial Spasm
Information
- Disease name
- Hemifacial Spasm
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT02761096 | Completed | N/A | Effect of Acupuncture on Inflammation and Immune Function After Craniotomy | April 2016 | November 2017 |
| NCT00276315 | Completed | Phase 3 | Assessment of Effectiveness and Safety of Dysport® for the Treatment of Hemifacial Spasm | December 2005 | January 2007 |
| NCT01168388 | Completed | Movement Disorder Survey in East China | April 2010 | August 2010 | |
| NCT00210431 | Completed | Post Marketing Surveillance Study of Dysport | October 2004 | June 2006 | |
| NCT05103202 | Completed | Efficacy and Safety of 10-Week or Shorter vs 12-Week or Longer Injection Intervals of Botulinum Toxin | November 4, 2021 | June 14, 2022 | |
| NCT04621578 | Completed | N/A | Transcutaneous Electrical Acupoint Stimulation on Postoperative Dizziness in Hemifacial Spasm Patients | December 6, 2020 | July 30, 2021 |
| NCT01598961 | Completed | N/A | Determination of Target of Adequate Partial Neuromuscular Blockade for Electrophysiologic Monitoring During Microvascular Decompression Surgery | May 2012 | April 2013 |
| NCT01613781 | Completed | N/A | Determination of Target of Adequate Partial Neuromuscular Blockade for Electrophysiologic Monitoring During Microvascular Decompression Surgery | June 2012 | February 2013 |
| NCT03508882 | Completed | Phase 4 | Pretarsal Versus Preseptal Botulinum Toxin for Patients With Eyelid Spasm | July 1, 2015 | February 20, 2019 |
| NCT01728428 | Completed | A Multicenter, Observational Study to Evaluate Clinical Manifestation, Diagnosis and Treatment of Primary Hemifacial Spasm in Chinese Patients | February 2012 | November 2012 | |
| NCT03390803 | Completed | Effect of Hemifacial Spasm on Intraocular Pressure Measurement | January 1, 2017 | December 20, 2017 | |
| NCT06195241 | Not yet recruiting | Phase 4 | Effects of DaxibotulinumtoxinA for Blepharospasm and Hemifacial Spasm | July 2024 | July 2026 |
| NCT04589364 | Not yet recruiting | Phase 3 | Study of Abobotulinum Toxin Versus Neubotulinum Toxin Injection For Hemifacial Spasm in Thai Patients | May 1, 2024 | August 1, 2026 |
| NCT04645277 | Recruiting | Magnetic Resonance Imaging Study on Patients With Hemifacial Spasm | January 1, 2021 | December 30, 2024 | |
| NCT01726725 | Unknown status | Hemifacial Spasm and Desflurane | November 2012 | December 2013 | |
| NCT04474977 | Unknown status | Microvascular Decompressive Surgery for Hemifacial Spasm | September 1, 2020 | March 1, 2023 | |
| NCT01271634 | Unknown status | Observe Abnormal Potential From the Offending Vessel to the Facial Muscles of HFS Patients | January 2011 | December 2011 | |
| NCT01564979 | Unknown status | Phase 2 | Effect on Tear Functions of Pretarsal and Preseptal Techniques of Botulinum Toxin Type A Injection in Hemifacial Spasm | April 2012 | December 2012 |
| NCT01546805 | Unknown status | N/A | Testing the Effect of Zinc Supplementation to Improve the Treatment Effect of Botulinum Toxin for Oculofacial Spasm | April 2012 | March 2013 |
| NCT03306940 | Unknown status | N/A | Botulinum Toxin A in the Treatment of Hemifacial Spasm | October 2, 2017 | August 31, 2018 |
| NCT01932255 | Withdrawn | CSF Leak Following Microvascular Decompression: the Benefit of Routine Postoperative Lumbar Tap | October 2013 | December 2014 |
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0010828
- MeSH unique ID (MeSH (Medical Subject Headings))
- D019569